## Abstract Osteopontin (OPN) plays roles in a variety of cellular processes from bone resorption and extracellular matrix (ECM) remodeling to immune cell activation and inhibition of apoptosis. Because it binds receptors (integrins, CD44 variants) typically engaged by ECM molecules, OPN acts as a
Pre- and post-translational regulation of osteopontin in cancer
✍ Scribed by Pieter H. Anborgh; Jennifer C. Mutrie; Alan B. Tuck; Ann F. Chambers
- Book ID
- 107594269
- Publisher
- Springer Netherlands
- Year
- 2011
- Tongue
- English
- Weight
- 343 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1873-9601
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Osteopontin (OPN) is primarily a secreted phosphoglycoprotein found in a variety of tissues and body fluids. It has a wide range of reported functions, many of which are affected by the degree of post‐translational modification (PTM) of the protein. These PTMs include phosphorylation, g
## Abstract PTEN is a critical tumor suppressor gene mutated frequently in various human cancers. Previous studies have showed that PTEN mRNA expression is down‐regulated by TGF‐β1 in various cell lines. In present study, we have found that TGF‐β1 down‐regulates PTEN mRNA and protein expression in
## Abstract Protease‐activated receptors (PARs) are a unique family of G‐protein‐coupled receptors (GPCRs) that are irreversibly activated following proteolytic cleavage of their extracellular N‐terminus. PARs play critical functions in hemostasis, thrombosis, inflammation, embryonic development, a